• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    61 Biggest Movers From Yesterday

    1/4/22 5:06:33 AM ET
    $AFI
    $AGE
    $APLT
    $ARQQ
    Building Products
    Capital Goods
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AFI alert in real time by email

    Gainers

    • Genprex, Inc. (NASDAQ:GNPX) shares surged 167.2% to settle at $3.50 on Monday. The FDA granted Fast Track Designation for Genprex’s lead drug candidate, Reqorsa Immunogene combination therapy.
    • Immix Biopharma, Inc. (NASDAQ:IMMX) shares jumped 62.4% to close at $5.78 on Monday. The FDA granted Rare Pediatric Disease (RPD) designation to newly listed Immix Biopharma's IMX-110 for rhabdomyosarcoma, a form of pediatric cancer.
    • Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) surged 44.8% to settle at $3.20. The stock may be seeing increased interested from retail investors.
    • Armstrong Flooring, Inc. (NYSE:AFI) jumped 39.9% to close at $2.77 as the company said it received $35 million capital infusion, and announced process for sale of company and consideration of other strategic alternatives.
    • Eco Wave Power Global AB (publ) (NASDAQ:WAVE) gained 39.9% to settle at $6.00.
    • Imperial Petroleum Inc. (NASDAQ:IMPP) jumped 34% to close at $2.60. Imperial Petroleum recently posted Q3 revenue of $4.1 million.
    • Airspan Networks Holdings Inc. (NYSE:MIMO) rose 27.4% to close at $4.83.
    • Applied UV, Inc. (NASDAQ:AUVI) climbed 25.2% to close at $3.38. Applied UV recently announced closing of $8.0 million underwritten public offering.
    • Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) gained 25.2% to settle at $1.59.
    • Smart Share Global Limited (NASDAQ:EM) gained 24.7% to close at $1.82.
    • ImmunityBio, Inc. (NASDAQ:IBRX) rose 23.9% to close at $7.53 after the company and Amyris announced the completion of a previously-announced joint venture for a COVID-19 RNA vaccine.
    • Pear Therapeutics, Inc. (NASDAQ:PEAR) shares gained 23.1% to close at $7.63. BTIG initiated coverage on Pear Therapeutics with a Buy rating and announced a price target of $12.
    • Moxian (BVI) Inc (NASDAQ:MOXC) surged 22.7% to close at $3.51.
    • Eqonex Limited (NASDAQ:EQOS) gained 22.5% to settle at $2.29.
    • Assertio Holdings, Inc. (NASDAQ:ASRT) climbed 21.6% to close at $2.65.
    • Intevac, Inc. (NASDAQ:IVAC) gained 21.4% to settle at $5.72 after the company announced the sale of Photonics business for $100 million.
    • Gilat Satellite Networks Ltd. (NASDAQ:GILT) gained 21.1% to close at $8.56 as the company said one of the world’s largest Mobile Network Operators will deploy 4G cellular backhaul over satellite technology from Gilat..
    • Unity Biotechnology, Inc. (NASDAQ:UBX) jumped 19.9% to settle at $1.75.
    • HeartBeam, Inc. (NASDAQ:BEAT) shares rose 19.2% to close at $3.67.
    • Kiromic BioPharma, Inc. (NASDAQ:KRBP) surged 19% to close at $1.82.
    • Organovo Holdings, Inc. (NASDAQ:ONVO) jumped 18.5% to settle at $4.30.
    • Vallon Pharmaceuticals, Inc. (NASDAQ:VLON) shares rose 18.4% to close at $7.08.
    • Omega Therapeutics, Inc. (NASDAQ:OMGA) gained 18.1% to close at $13.38.
    • Nine Energy Service, Inc. (NYSE:NINE) jumped 18% to close at $1.18.
    • BlueCity Holdings Limited (NASDAQ:BLCT) rose 17.7% to settle at $1.80 after the company announced it received an acquisition offer for the company at $3.70 per share.
    • Codere Online Luxembourg, S.A. (NASDAQ:CDRO) climbed 17.1% to close at $7.05.
    • PaySign, Inc (NASDAQ:PAYS) gained 16.9% to settle at $1.87.
    • Palisade Bio, Inc. (NASDAQ:PALI) jumped 16.2% to close at $1.51.
    • Groupon, Inc. (NASDAQ:GRPN) shares gained 15.9% to close at $26.83.
    • Nam Tai Property Inc. (NYSE:NTP) climbed 15.9% to close at $11.69.
    • Drive Shack Inc. (NYSE:DS) gained 15.4% to settle at $1.65.
    • Gevo, Inc. (NASDAQ:GEVO) rose 13.6% to close at $4.86.
    • Tesla, Inc. (NASDAQ:TSLA) climbed 13.5% to settle at $1,199.78 as the company reported record quarterly and annual deliveries that exceeded the most optimistic Wall Street forecasts.
    • Immunic, Inc. (NASDAQ:IMUX) jumped 12.1% to settle at $10.73.
    • Theravance Biopharma, Inc. (NASDAQ:TBPH) climbed 11.1% to close at $12.28.
    • Uranium Energy Corp. (NYSE:UEC) climbed 10.5% to close at $3.70. Uranium Energy, last month, posted a Q1 loss of $0.01 per share.
    • Uranium Royalty Corp. (NASDAQ:UROY) gained 8.8% to close at $3.97.
    • Orbsat Corp. (NASDAQ:OSAT) gained 8.7% to close at $3.51 as the company reported a $7.2 million private placement.
    • Frontline Ltd. (NYSE:FRO) rose 7.1% to settle at $7.57. Frontline, in November, reported third-quarter operating revenue of $171.8 million, a decline of 30.6% year-over-year.
    • Signet Jewelers Limited (NYSE:SIG) rose 6.9% to settle at $93.02.


    Check out these big penny stock gainers and losers

    Losers

    • Jowell Global Ltd. (NASDAQ:JWEL) dropped 59.2% to close at $8.79.
    • uCloudlink Group Inc. (NASDAQ:UCL) fell 42.3% to settle at $3.80 after climbing 32% on Friday.
    • Applied Therapeutics, Inc. (NASDAQ:APLT) shares fell 30.5% to close at $6.22. Following discussions with the FDA, Applied Therapeutics decided to hold on submitting a marketing application for AT-007 for Galactosemia pending additional talks with the agency.
    • Smith-Midland Corporation (NASDAQ:SMID) dropped 22% to close at $36.64.
    • VPC Impact Acquisition Holdings III, Inc. (NYSE:VPCC) shares declined 18.7% to close at $8.33.
    • Himax Technologies, Inc. (NASDAQ:HIMX) fell 18.6% to settle at $13.02.
    • Shineco, Inc. (NASDAQ:SISI) dropped 16.7% to close at $5.53.
    • Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX) fell 15.9% to close at $1.27.
    • FingerMotion, Inc. (NASDAQ:FNGR) dipped 15.3% to settle at $6.07.
    • Insignia Systems, Inc. (NASDAQ:ISIG) fell 14.7% to close at $19.68.
    • Arqit Quantum Inc. (NASDAQ:ARQQ) dropped 14.4% to settle at $20.51.
    • CNH Industrial N.V. (NYSE:CNHI) shares fell 13.8% to close at $16.74. CNH Industrial NV and Iveco Group executed the deed of demerger whereby, effective January 1, 2022, the relevant Iveco Group business segments separated from CNH Industrial.
    • Crown ElectroKinetics Corp. (NASDAQ:CRKN) dropped 13.5% to settle at $3.45.
    • Fathom Digital Manufacturing Corporation (NYSE:FATH) fell 12.9% to close at $6.90 after surging 22% on Friday.
    • AgeX Therapeutics, Inc. (NASDAQ:AGE) fell 12.8% to close at $0.95 after jumping 85% on Friday. AgeX Therapeutics recently announced plans to collaborate with University of California, Irvine, on research program for exosome-based therapies for certain brain disorders.
    • Heliogen, Inc. (NASDAQ:HLGN) dropped 12.6% to close at $13.57 after jumping around 62% on Friday.
    • Medalist Diversified REIT, Inc. (NASDAQ:MDRR) shares fell 11.7% to close at $1.06. Medalist Diversified REIT shares jumped around 18% on Friday after the company announced a stock repurchase program of 500,000 shares.
    • MongoDB, Inc. (NASDAQ:MDB) dipped 7.9% to settle at $487.56.
    • Moderna, Inc. (NASDAQ:MRNA) fell 7.5% to close at $235.05. Moderna recently announced supply agreement with South Korea for additional 20 million doses of its COVID-19 vaccine or updated booster candidate in 2022.
    • Nutriband Inc. (NASDAQ:NTRB) fell 6.5% to settle at $9.43. Nutriband shares climbed 158% on Friday after the company announced the Korean Intellectual Property Office has fully issued its patent titled "Abuse and Misuse Deterrent Transdermal System" which is related to the company's lead technology AVERSA.
    • Kingsoft Cloud Holdings Limited (NASDAQ:KC) dropped 6.2% to close at $14.77. Goldman Sachs downgraded Kingsoft Cloud from Buy to Neutral and lowered the price target from $37 to $18.
    Get the next $AFI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AFI
    $AGE
    $APLT
    $ARQQ

    CompanyDatePrice TargetRatingAnalyst
    Himax Technologies Inc.
    $HIMX
    2/4/2026$8.00Overweight → Equal-Weight
    Morgan Stanley
    Tesla Inc.
    $TSLA
    1/30/2026$150.00 → $145.00Underweight
    Analyst
    Codere Online Luxembourg S.A.
    $CDRO
    1/30/2026$8.50Buy → Hold
    Stifel
    Moderna Inc.
    $MRNA
    1/28/2026$25.00Equal Weight
    Barclays
    Tesla Inc.
    $TSLA
    1/12/2026$120.00 → $130.00Underweight
    Wells Fargo
    Frontline Plc
    $FRO
    1/12/2026Neutral → Buy
    Clarksons Platou
    Palisade Bio Inc.
    $PALI
    1/9/2026$7.00Buy
    B. Riley Securities
    Moderna Inc.
    $MRNA
    1/7/2026$34.00Neutral
    UBS
    More analyst ratings

    $AFI
    $AGE
    $APLT
    $ARQQ
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Williams Donald Allen bought $8,356 worth of shares (5,000 units at $1.67), increasing direct ownership by 87% to 10,728 units (SEC Form 4)

    4 - PALISADE BIO, INC. (0001357459) (Issuer)

    1/21/26 4:05:24 PM ET
    $PALI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Director Williams Donald Allen bought $9,400 worth of shares (5,000 units at $1.88), increasing direct ownership by 687% to 5,728 units (SEC Form 4)

    4 - PALISADE BIO, INC. (0001357459) (Issuer)

    1/13/26 9:43:07 PM ET
    $PALI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Director Leong Yew Poh decreased direct ownership by 6% to 160,000 units (SEC Form 4)

    4 - FingerMotion, Inc. (0001602409) (Issuer)

    12/29/25 6:26:12 AM ET
    $FNGR
    Computer Software: Prepackaged Software
    Technology

    $AFI
    $AGE
    $APLT
    $ARQQ
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Himax Tech downgraded by Morgan Stanley with a new price target

    Morgan Stanley downgraded Himax Tech from Overweight to Equal-Weight and set a new price target of $8.00

    2/4/26 8:28:23 AM ET
    $HIMX
    Semiconductors
    Technology

    Analyst reiterated coverage on Tesla with a new price target

    Analyst reiterated coverage of Tesla with a rating of Underweight and set a new price target of $145.00 from $150.00 previously

    1/30/26 8:00:23 AM ET
    $TSLA
    Auto Manufacturing
    Industrials

    Codere Online Luxembourg, S.A. downgraded by Stifel with a new price target

    Stifel downgraded Codere Online Luxembourg, S.A. from Buy to Hold and set a new price target of $8.50

    1/30/26 6:42:39 AM ET
    $CDRO
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    $AFI
    $AGE
    $APLT
    $ARQQ
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    November 30, 2020 - Coronavirus (COVID-19) Update: FDA Announces Advisory Committee Meeting to Discuss Second COVID-19 Vaccine Candidate

    For Immediate Release: November 30, 2020 The U.S. Food and Drug Administration has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 17 to discuss the request for emergency use authorization (EUA) for a COVID-19 vaccine from Moderna, Inc. “In keeping with the FDA’s commitment to ensuring full transparency, dialogue and efficiency, the Vaccines and Related Biological Products Advisory Comm

    11/30/20 5:12:14 PM ET
    $MRNA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AFI
    $AGE
    $APLT
    $ARQQ
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Killalea Peter Thomas exercised 30,000 shares at a strike of $6.50, increasing direct ownership by 93% to 62,293 units (SEC Form 4)

    4 - MongoDB, Inc. (0001441816) (Issuer)

    2/6/26 1:59:45 PM ET
    $MDB
    Computer Software: Prepackaged Software
    Technology

    Director Merriman Dwight A sold $440,002 worth of shares (1,190 units at $369.75) (SEC Form 4)

    4 - MongoDB, Inc. (0001441816) (Issuer)

    2/4/26 4:27:20 PM ET
    $MDB
    Computer Software: Prepackaged Software
    Technology

    Director Kanter Stacy J. returned 22,500 shares to the company, closing all direct ownership in the company (SEC Form 4)

    4 - Applied Therapeutics, Inc. (0001697532) (Issuer)

    2/4/26 11:17:54 AM ET
    $APLT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AFI
    $AGE
    $APLT
    $ARQQ
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Anfield Energy Announces Special Shareholder Meeting and Mailing of Related Documents

    VANCOUVER, British Columbia, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Anfield Energy Inc. (TSX.V: AEC, NASDAQ:AEC, FRANKFURT: 0AD) ("Anfield" or the "Company") announces that today is the legal mailing date for the mailing and filing of the notice of a meeting of shareholders, the management information circular, and related documents (collectively, the "Meeting Materials") to convene a special meeting (the "Meeting") of shareholders. The Meeting will take place on February 27, 2026 at 10:00 AM (Vancouver Time). Copies of the Meeting Materials are available for review under the profile for the Company on SEDAR+ (www.sedarplus.ca) and on Anfield's corporate website (https://anfieldenergy.com). Th

    2/6/26 4:30:00 PM ET
    $AEC
    $UEC
    Metal Mining
    Basic Materials
    Other Metals and Minerals

    The $71 Billion Cancer Shift: Why The FDA Is Speeding Up

    VANCOUVER, British Columbia, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Equity-Insider.com News Commentary – The market is waking up to a $71 billion reality[1]. We are seeing a decisive move away from broad chemotherapy and toward precision biologics like mRNA and oncolytic viruses. The FDA is actively accelerating this cycle, having granted multiple breakthrough designations in January 2026 alone for platforms that demonstrate genuine survival durability[2]. This structural realignment positions Oncolytics Biotech Inc. (NASDAQ:ONCY), Moderna (NASDAQ:MRNA), Immunome (NASDAQ:IMNM), Autolus Therapeutics (NASDAQ:AUTL), and Prelude Therapeutics (NASDAQ:PRLD) within the emerging biological innovation c

    2/5/26 9:26:03 AM ET
    $AUTL
    $IMNM
    $MRNA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    Palisade Bio to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference

    Virtual presentation scheduled for Thursday, February 26th at 12:40 PM ET Access the webcast here Carlsbad, CA, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (NASDAQ:PALI) ("Palisade" or the "Company"), a clinical-stage biopharmaceutical company developing next-generation, once-daily, oral PDE4 inhibitor prodrugs designed for targeted delivery to the terminal ileum and colon, today announced that JD Finley, Chief Executive Officer, and Dr. Mitchell Jones, President and Chief Medical Officer, will present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference, being held in a virtual format February 25–26, 2026. The Company's virtual presentation is scheduled for Thur

    2/5/26 8:45:00 AM ET
    $PALI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AFI
    $AGE
    $APLT
    $ARQQ
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Nine Energy Service Inc.

    SCHEDULE 13G/A - Nine Energy Service, Inc. (0001532286) (Subject)

    2/6/26 5:54:44 PM ET
    $NINE
    Oilfield Services/Equipment
    Energy

    SEC Form S-8 filed by Uranium Energy Corp.

    S-8 - URANIUM ENERGY CORP (0001334933) (Filer)

    2/6/26 4:30:58 PM ET
    $UEC
    Other Metals and Minerals
    Basic Materials

    Amendment: SEC Form SCHEDULE 13G/A filed by Moderna Inc.

    SCHEDULE 13G/A - Moderna, Inc. (0001682852) (Subject)

    2/6/26 1:10:23 PM ET
    $MRNA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AFI
    $AGE
    $APLT
    $ARQQ
    Leadership Updates

    Live Leadership Updates

    View All

    Palisade Bio Appoints Leading Global IBD Experts, Laurent Peyrin-Biroulet, MD, PhD and David T. Rubin, MD, to Its Clinical Advisory Board

    Internationally recognized leaders in inflammatory bowel disease bring deep expertise spanning ulcerative colitis, Crohn's disease, and late-stage clinical trial design Appointments strengthen Palisade Bio's clinical strategy as PALI-2108 advances toward Phase 2 development in ulcerative colitis and fibrostenotic Crohn's disease, with a Phase 2 UC IND submission planned for the first half of 2026 Carlsbad, CA, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (NASDAQ:PALI) ("Palisade" or the "Company"), a clinical-stage biopharmaceutical company developing next-generation, once-daily, oral PDE4 inhibitor prodrugs designed for targeted delivery to the terminal ileum and colon, today an

    1/29/26 8:45:00 AM ET
    $PALI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    HeartBeam Appoints Bryan Humbarger as Chief Commercial Officer

    Brings more than 25 years of experience in building and scaling groundbreaking cardiovascular technologies Will initially focus on launching the Company's FDA-cleared 12-lead ECG system for arrhythmia assessment Will lead the Company's broader commercialization strategy across key growth initiatives, including heart attack detection and the 12-lead ECG extended-wear patch HeartBeam, Inc. (NASDAQ:BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced the appointment of Bryan Humbarger as Chief Commercial Officer, effective January 22, 2026. In this newly created role, Mr. Humbarger will lead commercial strate

    1/22/26 7:00:00 AM ET
    $BEAT
    Medical/Dental Instruments
    Health Care

    The $185B Cancer Surge: Why the FDA's Fast-Track Pivot is Scaling a New Immunotherapy Era

    VANCOUVER, British Columbia, Jan. 14, 2026 (GLOBE NEWSWIRE) -- USANewsGroup.com News Commentary – The global immuno-oncology market is set to explode from its current $35 billion level to a massive $185.69 billion by 2035 as the industry moves toward the coordinated activation of the immune system[1]. This surge is being accelerated by the $69.16 billion genomics revolution, which is now integrating advanced profiling into every oncology workflow to pick winning treatments[2]. This strategic push for registration-ready precision assets fuels the 2026 investment case for Oncolytics Biotech Inc. (NASDAQ:ONCY), ImmunityBio (NASDAQ:IBRX), OS Therapies (NYSE-A: OSTX), BioNTech SE (NASDAQ:BNTX),

    1/14/26 10:39:59 AM ET
    $BNTX
    $CMPX
    $IBRX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    $AFI
    $AGE
    $APLT
    $ARQQ
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Analysis: Purchase at Assertio Holdings Inc. on Jun 6

    Recent insider transactions at Assertio Holdings Inc. have brought attention to the company's stock activity. On June 6, 2024, Mason Heather L purchased $24,250 worth of shares, acquiring 25,000 units at $0.97 per share. This transaction increased Mason Heather L's direct ownership by 13% to 212,650 units, as reported in the SEC Form 4. Several other notable insider transactions have taken place at Assertio Holdings Inc. leading up to this purchase. Patel Ajay, Schwichtenberg Paul, and Schlessinger Sam all converted options into shares and covered exercise/tax liability by utilizing their shares. These transactions resulted in ownership increases of 16%, 20%, and 21%, respectively. Addition

    6/10/24 1:20:50 AM ET
    $ASRT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Insider Analysis: Purchase at Immix Biopharma Inc. on Jun 5

    Recent insider purchases at Immix Biopharma Inc. have caught the attention of investors, with Morris Gabriel S leading the way by acquiring $5,973 worth of shares on June 5, 2024. This transaction involved 3,300 units at a price of $1.81 per share, increasing Gabriel's direct ownership by 1% to 283,334 units, as reported in SEC Form 4. This move indicates Gabriel's confidence in the company's potential and may be seen as a positive signal by market participants. Click here for more details. Looking back at previous insider transactions, we can identify a few interesting patterns. On May 15, 2024, Rachman Ilya M purchased $9,660 worth of shares, comprising 4,300 units at $2.25 per share, whi

    6/10/24 1:09:24 AM ET
    $IMMX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AFI
    $AGE
    $APLT
    $ARQQ
    Financials

    Live finance-specific insights

    View All

    MongoDB, Inc. Announces Date of Fourth Quarter and Full Fiscal 2026 Earnings Call

    NEW YORK, Feb. 4, 2026 /PRNewswire/ -- MongoDB, Inc. (NASDAQ:MDB) will report its fourth quarter and full fiscal year 2026 financial results for the three months ended January 31, 2026, after the U.S. financial markets close on Monday, March 2, 2026. In conjunction with this announcement, MongoDB will host a conference call on Monday, March 2, 2026, at 5:00 p.m. (Eastern Time) to discuss the Company's financial results and business outlook. A live webcast of the call will be available on the "Investor Relations" page of the Company's website at http://investors.mongodb.com. To

    2/4/26 4:05:00 PM ET
    $MDB
    Computer Software: Prepackaged Software
    Technology

    Cycle Pharmaceuticals Completes Acquisition of Applied Therapeutics

    Cycle Group Holdings Limited ("Cycle") is delighted to announce it has completed the acquisition of NASDAQ-listed Applied Therapeutics, Inc. (NASDAQ:APLT, "Applied")), a clinical-stage biopharmaceutical company. Applied's lead drug candidate, govorestat, is a novel central nervous system (CNS) penetrant Aldose Reductase Inhibitor (ARI) for the treatment of CNS rare metabolic diseases, including Classic Galactosemia, Charcot-Marie-Tooth Sorbitol Dehydrogenase Deficiency (CMT-SORD) and phosphomannomutase 2 congenital disorder of glycosylation (PMM2-CDG), for which there are currently no FDA approved treatment options available. "Cycle was founded with a commitment to support patients livi

    2/3/26 8:39:00 AM ET
    $APLT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Gilat to Report Fourth Quarter and Full Year 2025 Results on Tuesday, February 10

    PETAH TIKVA, Israel, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (NASDAQ:GILT, TASE: GILT)), a worldwide leader in satellite networking technology, solutions and services, today announced that it will release its fourth quarter and full year 2025 financial results on Tuesday, February 10, 2026. Conference Call and Webcast Following the release, Adi Sfadia, Chief Executive Officer, and Gil Benyamini, Chief Financial Officer, will discuss Gilat's fourth quarter 2025 results and business achievements and participate in a question and answer session: In English: Date:Tuesday, February 10, 2026Start:08:30 AM EST / 15:30 IST   A simultaneous webcast of the conference call w

    1/22/26 7:05:19 AM ET
    $GILT
    Radio And Television Broadcasting And Communications Equipment
    Technology

    $AFI
    $AGE
    $APLT
    $ARQQ
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Arqit Quantum Inc.

    SC 13D/A - Arqit Quantum Inc. (0001859690) (Subject)

    12/13/24 8:03:28 PM ET
    $ARQQ
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13G filed by Groupon Inc.

    SC 13G - Groupon, Inc. (0001490281) (Subject)

    12/13/24 10:39:00 AM ET
    $GRPN
    Advertising
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Arqit Quantum Inc.

    SC 13D/A - Arqit Quantum Inc. (0001859690) (Subject)

    12/10/24 8:05:26 PM ET
    $ARQQ
    Computer Software: Prepackaged Software
    Technology